Help reduce the risk of bloodstream infections at all access points.

EXPLORE 3M SOLUTIONS

Often the first entry into a patient’s body, intravenous therapy remains a common and critical intervention, but it is not without risks. Catheter-associated bloodstream infections (CABSIs) can be acquired at the time of the initial insertion or anytime throughout the duration of venous access — creating the potential for longer hospital stays, increased care costs and higher patient mortality. Incorporating evidence-based standards to IV insertion, care and maintenance can help protect against the factors that may lead to increased risk of bloodstream infection.

60% of all CABSIs originate from some form of vascular access.¹
1 in 4 patients who contract a CABSI will die.²
The cost to treat one CABSI averaged $45,000 USD per patient.³,⁴

Healthcare professional setting out catheter parts on a table

Best practices for preventing infection in clinical settings.

The Infusion Nurses Society (INS) is a global authority on infusion therapy, setting stringent standards for practice. Every five years, INS releases updated, peer-reviewed standards that reflect the latest evidence to define and develop best practices for all clinical settings. 3M can help you stay up to date so you can help deliver better patient outcomes.

SEE SELECT HIGHLIGHTS

We can help you meet current guidelines with evidence-based solutions.

Protecting patients from CABSIs requires a commitment from the care team to methodically adhere to evidence-based standards established by well-regarded organizations such as INS, SHEA, APIC and CDC.

3M partners with you, offering a portfolio of innovative solutions to help you protect every IV catheter site — from insertion to removal — every time. From hand hygiene and barrier films to securement devices, disinfecting caps and more, our evidence-based products help you deliver compassionate care, protect patients, help prevent the risks of costly complications, and improve patient satisfaction.

Need more information? Connect with 3M.

3M™ Tegaderm™ I.V. Advanced Securement Dressings

Antimicrobial IV Dressings
Antimicrobial IV Dressings
3M™ Tegaderm™ CHG I.V. Securement Dressings

3M™ Tegaderm™ CHG Chlorhexidine Gluconate I.V. Securement Dressing* is the only transparent dressing cleared by the FDA to reduce catheter-related bloodstream infections (CRBSI) and vascular catheter colonization that aligns with evidence-based guidelines and practice standards.

Integrated IV dressing combines infection reduction with site visibility, catheter securement, and breathability

Provides immediate and continuous antimicrobial protection with integrated (CHG) gel pad

Helps keep catheters in place with large securement tape strip and conforming keyhole notch

3M™ Tegaderm™ CHG Dressings

*Important Safety Information for 3M™ Tegaderm™ CHG Chlorhexidine Gluconate I.V. Securement Dressing. Do not use 3M™ Tegaderm™ CHG I.V. Securement Dressing on premature infants or infants younger than two months of age. Use of this product on premature infants may result in hypersensitivity reactions or necrosis of the skin.The safety and effectiveness of 3M™ Tegaderm™ CHG I.V. Securement Dressing has not been established in children under 18 years of age. For full prescribing information, see the Instructions for Use (IFU). Rx only.
Securement Dressings and Devices
Securement Dressings and Devices
3M™ Tegaderm™ I.V. Advanced Securement Dressings

3M™ Tegaderm™ I.V. Advanced Securement Dressings meet the 2021 Infusion Therapy Standards of Practice definition of an integrated securement device (IAD)⁵ and are designed to stabilize and secure vascular access securements (VADs).⁶

Designed to maintain securement by preventing edge lift, flexing with patient movement and managing moisture

A cost-effective IV and central line catheter securement solution

Available with and without CHG*

3M™ Tegaderm™ I.V. Advanced Securement Dressings

3M™ PICC/CVC Securement Devices

Secure IVs quickly and effectively — without sutures. Designed to enhance patient comfort and mobility, they are an easy to apply/easy to remove securement system that can be worn for up to 7 days. Integrated CHG* gel pad provides immediate and continuous antimicrobial protection.

Accommodates the majority of PICC and CVC catheters

Eliminates the risks and costs of suture-related needlestick injuries

Easy to apply and remove

Integrated microbial protection

3M™ PICC/CVC Securement Devices

*Important Safety Information for 3M™ Tegaderm™ CHG Chlorhexidine Gluconate I.V. Securement Dressing. Do not use 3M™ Tegaderm™ CHG I.V. Securement Dressing on premature infants or infants younger than two months of age. Use of this product on premature infants may result in hypersensitivity reactions or necrosis of the skin.The safety and effectiveness of 3M™ Tegaderm™ CHG I.V. Securement Dressing has not been established in children under 18 years of age. For full prescribing information, see the Instructions for Use (IFU). Rx only.
Port Protectors

Port Protectors

3M™ Curos™ Disinfecting Port Protectors

3M™ Curos™ Disinfecting Port Protectors* are 70% isopropyl alcohol (IPA) containing caps that twist onto IV access points – disinfecting them in 1 minute and protecting them from contamination for up to 7 days if not removed.

The 2021 Infusion Therapy Standards of Practice states that disinfecting caps containing 70% isopropyl alcohol were associated with lower rates of catheter-associated bloodstream infection (CABSI), while 70% isopropyl alcohol swabs were found to be least effective based on a meta-analysis of quasi-experimental studies.⁵

3M™ Curos™ Disinfecting Port Protectors

*For full prescribing information, see the Instructions for Use (IFU). Rx only.
Hand Antiseptic
Hand Antiseptic
3M™ Avagard™ Hand Antiseptic

Hands are the most common source of pathogen transmission. That’s why 3M developed a portfolio of hand hygiene solutions to help you protect your patients by reducing the risk of healthcare associated infections. For hand hygiene, the 2021 Infusion Therapy Standards of Practice currently recommends using soap and water, or as an alternative, using an alcohol-based hand rub that contains at least 60% alcohol or 70% isopropyl alcohol.⁵ 3M™ Avagard™ Hand Antiseptic meets those standards while providing additional benefits:

Emollient rich formulation contains 61% w/w ethyl alchohol

Available with and without CHG*

Gentle enough to promote repeated and frequent use

3M™ Avagard™ Hand Antiseptic

*For full prescribing information, see the Instructions for Use (IFU). Rx only.
Skin Barrier
Skin Barrier
3M™ Cavilon™ No Sting Barrier Film

Scientifically formulated and proven to help protect skin around vascular access sites. In fact, it’s supported by vascular access-specific data.⁷⁻¹⁰

Waterproof, yet breathable

Unique packaging allows for aseptic delivery

Alcohol-free and sting-free¹⁰

3M™ Cavilon™ No Sting Barrier Film

Health Care Professional in ICU with a patient

Comprehensive Infection Prevention

3M takes a holistic approach to help you identify and reduce infection and transmission risks, navigate rapidly changing standards and guidelines, and provide science-based solutions that can help you protect patients, staff and everyone who enters your facility.

PROACTIVELY PREVENT INFECTIONS

3M resources to help you stay informed.

Close

Thank You

Thank you for connecting with 3M! We’ll be in touch with you shortly.

Our Apologies...

An error has occurred while submitting. Please try again later...

1. Maki D, Mermel L: Infections due to infusion therapy. In Hospital Infections, edn 4.Edited by Bennett JV, Brachman PS. Philadelphia: Lippincott-Raven; 1998:689–724.
2. CDC Vital Signs: Making health care safer: Reducing bloodstream infections. Centers for Disease Control and Prevention website. https://www.cdc.gov/vitalsigns/pdf/2011-03-vitalsigns.pdf Published March, 2011. Accessed June 18, 2017.
3. Blot SI, Depuydt P, Annemans L, Benoit D, Hoste E, De Waele JJ, Decruyenaere J, Vogelaers D, Colardyn F, Vandewoude KH. Clinical and economic outcomes in critically ill patients with nosocomial catheter-related bloodstream infections. Clin Infect Dis. 2005 Dec 1;41(11):1591-1598
4. Zimlichman E, Henderson D, et al. Health Care–Associated Infections: A Meta-analysis of Costs and Financial Impact on the US Health Care System. JAMA Intern Med. 2013 Dec 9-23;173(22):2039-2046. doi: 10.1001/ jamainternmed.2013.9763
5. Gorski, L. A., Hadaway, L., Hagle, M.E., Broadhurst, D., Clare, S., Kleidon, T., Meyer, B.M., Nickel, B., Rowley, S., Sharpe, E., Alexander, M. (2021). Journal of Infusion Nursing, 44(suppl 1):S1-S224. doi:10.1097/NAN.0000000000000396. Refer to the document to view verbatim, comprehensive standards and practice recommendations.
6. 3M data on file: EM-05-014359.
7. George M, Ujwala P, Guduri, V, & Smith G. Use of a barrier film (3M™ Cavilon™ No Sting Barrier Film) to reduce local skin complications around peripherally inserted central catheter lines: A randomised prospective controlled study. WCET Journal. 2016; 8-13.
8. Pivkina AI, Gusarov VG, Blot SI, Zhivotneva IV, Pasko NV, Zamyatin MN. Effect of an acrylic terpolymer barrier film beneath transparent catheter dressings on skin integrity, risk of dressing disruption, catheter colonisation and infection. Intensive Crit Care Nurs. 2018; 46: 17-23.
9. Chen Y-H, Hsieh H-L, Shih W-M. Applying skin barrier film for skin tear management in patients with central venous catheterization. Adv Skin Wound Care. 2020; 33: 582-586.
10. Campbell K, Woodbury MG, Whittle H, Labate T, Hoskin A. A clinical evaluation of 3M™ Cavilon™ No Sting Barrier Film. Ostomy Wound Management.2000;46(1):24-30.